nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—chronic kidney failure	0.353	0.423	CbGaD
Pomalidomide—CYP3A4—chronic kidney failure	0.171	0.205	CbGaD
Pomalidomide—PTGS2—chronic kidney failure	0.167	0.201	CbGaD
Pomalidomide—ABCB1—chronic kidney failure	0.142	0.171	CbGaD
Pomalidomide—Thalidomide—NFKB1—chronic kidney failure	0.00325	0.381	CrCbGaD
Pomalidomide—TNF—blood—chronic kidney failure	0.00301	0.0842	CbGeAlD
Pomalidomide—PTGS2—nephron—chronic kidney failure	0.00255	0.0714	CbGeAlD
Pomalidomide—CYP1A2—urine—chronic kidney failure	0.00247	0.0692	CbGeAlD
Pomalidomide—CRBN—nephron tubule—chronic kidney failure	0.00203	0.0566	CbGeAlD
Pomalidomide—CRBN—renal system—chronic kidney failure	0.00184	0.0515	CbGeAlD
Pomalidomide—CRBN—urethra—chronic kidney failure	0.00181	0.0506	CbGeAlD
Pomalidomide—CYP3A4—urine—chronic kidney failure	0.00179	0.0501	CbGeAlD
Pomalidomide—CRBN—cortex of kidney—chronic kidney failure	0.00173	0.0485	CbGeAlD
Pomalidomide—CRBN—gonad—chronic kidney failure	0.00165	0.0462	CbGeAlD
Pomalidomide—CRBN—digestive system—chronic kidney failure	0.00151	0.0422	CbGeAlD
Pomalidomide—CRBN—blood—chronic kidney failure	0.00144	0.0402	CbGeAlD
Pomalidomide—PTGS2—artery—chronic kidney failure	0.00143	0.0399	CbGeAlD
Pomalidomide—CYP1A2—blood plasma—chronic kidney failure	0.00129	0.0361	CbGeAlD
Pomalidomide—PTGS2—blood plasma—chronic kidney failure	0.00107	0.0299	CbGeAlD
Pomalidomide—Thalidomide—TNF—chronic kidney failure	0.000995	0.117	CrCbGaD
Pomalidomide—CYP3A4—blood plasma—chronic kidney failure	0.000934	0.0261	CbGeAlD
Pomalidomide—Thalidomide—PTGS1—chronic kidney failure	0.000827	0.0971	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—chronic kidney failure	0.000789	0.0926	CrCbGaD
Pomalidomide—Thalidomide—CYP2C19—chronic kidney failure	0.000759	0.0891	CrCbGaD
Pomalidomide—Thalidomide—CYP1A1—chronic kidney failure	0.000757	0.0888	CrCbGaD
Pomalidomide—Lenalidomide—ABCB1—chronic kidney failure	0.000671	0.0788	CrCbGaD
Pomalidomide—ABCB1—blood plasma—chronic kidney failure	0.000661	0.0185	CbGeAlD
Pomalidomide—CYP1A2—renal system—chronic kidney failure	0.000605	0.0169	CbGeAlD
Pomalidomide—PTGS2—renal system—chronic kidney failure	0.000501	0.014	CbGeAlD
Pomalidomide—CYP1A2—digestive system—chronic kidney failure	0.000496	0.0139	CbGeAlD
Pomalidomide—PTGS2—cardiovascular system—chronic kidney failure	0.000495	0.0139	CbGeAlD
Pomalidomide—PTGS2—urethra—chronic kidney failure	0.000492	0.0138	CbGeAlD
Pomalidomide—PTGS2—kidney—chronic kidney failure	0.000485	0.0136	CbGeAlD
Pomalidomide—CYP1A2—blood—chronic kidney failure	0.000473	0.0132	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—chronic kidney failure	0.000473	0.0555	CrCbGaD
Pomalidomide—CYP3A4—renal system—chronic kidney failure	0.000438	0.0123	CbGeAlD
Pomalidomide—CYP3A4—kidney—chronic kidney failure	0.000424	0.0118	CbGeAlD
Pomalidomide—PTGS2—digestive system—chronic kidney failure	0.000411	0.0115	CbGeAlD
Pomalidomide—PTGS2—blood—chronic kidney failure	0.000392	0.011	CbGeAlD
Pomalidomide—CYP3A4—digestive system—chronic kidney failure	0.000359	0.01	CbGeAlD
Pomalidomide—CYP3A4—blood—chronic kidney failure	0.000342	0.00957	CbGeAlD
Pomalidomide—ABCB1—nephron tubule—chronic kidney failure	0.000341	0.00954	CbGeAlD
Pomalidomide—ABCB1—renal system—chronic kidney failure	0.00031	0.00867	CbGeAlD
Pomalidomide—ABCB1—cardiovascular system—chronic kidney failure	0.000306	0.00857	CbGeAlD
Pomalidomide—ABCB1—urethra—chronic kidney failure	0.000305	0.00852	CbGeAlD
Pomalidomide—ABCB1—kidney—chronic kidney failure	0.0003	0.00838	CbGeAlD
Pomalidomide—ABCB1—cortex of kidney—chronic kidney failure	0.000292	0.00816	CbGeAlD
Pomalidomide—ABCB1—gonad—chronic kidney failure	0.000278	0.00778	CbGeAlD
Pomalidomide—ABCB1—digestive system—chronic kidney failure	0.000254	0.00711	CbGeAlD
Pomalidomide—ABCB1—blood—chronic kidney failure	0.000242	0.00678	CbGeAlD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—chronic kidney failure	4.78e-05	0.000392	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	4.74e-05	0.000388	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	4.73e-05	0.000388	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ACAT1—chronic kidney failure	4.71e-05	0.000386	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	4.65e-05	0.000381	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	4.63e-05	0.000379	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	4.6e-05	0.000377	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	4.57e-05	0.000375	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	4.51e-05	0.00037	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—chronic kidney failure	4.49e-05	0.000368	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	4.45e-05	0.000365	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TFDP2—chronic kidney failure	4.45e-05	0.000364	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	4.39e-05	0.00036	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—chronic kidney failure	4.39e-05	0.00036	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MLXIPL—chronic kidney failure	4.38e-05	0.000359	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—chronic kidney failure	4.38e-05	0.000359	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP1A1—chronic kidney failure	4.37e-05	0.000358	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIP5K1B—chronic kidney failure	4.35e-05	0.000357	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic kidney failure	4.31e-05	0.000353	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	4.3e-05	0.000352	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—chronic kidney failure	4.28e-05	0.000351	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCC3—chronic kidney failure	4.27e-05	0.00035	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GCKR—chronic kidney failure	4.27e-05	0.00035	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—chronic kidney failure	4.19e-05	0.000344	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—chronic kidney failure	4.1e-05	0.000336	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCC2—chronic kidney failure	4.09e-05	0.000336	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC22A2—chronic kidney failure	4e-05	0.000328	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	3.96e-05	0.000325	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	3.96e-05	0.000325	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.91e-05	0.000321	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FABP1—chronic kidney failure	3.85e-05	0.000316	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCG1—chronic kidney failure	3.72e-05	0.000305	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	3.71e-05	0.000304	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	3.67e-05	0.0003	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGXT—chronic kidney failure	3.65e-05	0.000299	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GATM—chronic kidney failure	3.65e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIP5K1B—chronic kidney failure	3.64e-05	0.000299	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	3.61e-05	0.000296	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	3.59e-05	0.000294	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ARG2—chronic kidney failure	3.57e-05	0.000293	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	3.51e-05	0.000288	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LCAT—chronic kidney failure	3.5e-05	0.000287	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	3.44e-05	0.000282	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—chronic kidney failure	3.38e-05	0.000277	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	3.37e-05	0.000276	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GCKR—chronic kidney failure	3.37e-05	0.000276	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACAT1—chronic kidney failure	3.34e-05	0.000274	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	3.33e-05	0.000273	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	3.33e-05	0.000273	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RELA—chronic kidney failure	3.29e-05	0.000269	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—chronic kidney failure	3.26e-05	0.000267	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LRP2—chronic kidney failure	3.23e-05	0.000265	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DDC—chronic kidney failure	3.21e-05	0.000263	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PRKD1—chronic kidney failure	3.12e-05	0.000256	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PRKAG2—chronic kidney failure	3.12e-05	0.000256	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2B6—chronic kidney failure	3.12e-05	0.000256	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MLXIPL—chronic kidney failure	3.1e-05	0.000254	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FABP1—chronic kidney failure	3.07e-05	0.000252	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	3.07e-05	0.000252	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	3.05e-05	0.00025	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CYBB—chronic kidney failure	3e-05	0.000246	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	2.99e-05	0.000245	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.97e-05	0.000243	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	2.92e-05	0.00024	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SREBF2—chronic kidney failure	2.92e-05	0.000239	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGXT—chronic kidney failure	2.91e-05	0.000239	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GATM—chronic kidney failure	2.91e-05	0.000239	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	2.85e-05	0.000234	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	2.85e-05	0.000233	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	2.85e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF23—chronic kidney failure	2.84e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CST3—chronic kidney failure	2.84e-05	0.000233	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC22A2—chronic kidney failure	2.84e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	2.83e-05	0.000232	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCC3—chronic kidney failure	2.82e-05	0.000231	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCKR—chronic kidney failure	2.82e-05	0.000231	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NFKB1—chronic kidney failure	2.77e-05	0.000227	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPIN1—chronic kidney failure	2.76e-05	0.000226	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.71e-05	0.000222	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LRP2—chronic kidney failure	2.71e-05	0.000222	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2C18—chronic kidney failure	2.71e-05	0.000222	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACAT1—chronic kidney failure	2.67e-05	0.000218	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCG1—chronic kidney failure	2.64e-05	0.000216	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.63e-05	0.000216	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.6e-05	0.000213	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	2.6e-05	0.000213	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	2.58e-05	0.000212	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.55e-05	0.000209	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ARG2—chronic kidney failure	2.53e-05	0.000207	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—chronic kidney failure	2.52e-05	0.000206	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—chronic kidney failure	2.52e-05	0.000206	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.49e-05	0.000204	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LCAT—chronic kidney failure	2.48e-05	0.000203	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MLXIPL—chronic kidney failure	2.48e-05	0.000203	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCF1—chronic kidney failure	2.47e-05	0.000203	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.43e-05	0.000199	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FABP1—chronic kidney failure	2.37e-05	0.000194	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	2.36e-05	0.000193	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CYBA—chronic kidney failure	2.32e-05	0.000191	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—chronic kidney failure	2.31e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CPT1A—chronic kidney failure	2.3e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FASN—chronic kidney failure	2.29e-05	0.000187	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DDC—chronic kidney failure	2.28e-05	0.000187	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC22A2—chronic kidney failure	2.27e-05	0.000186	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGXT—chronic kidney failure	2.25e-05	0.000184	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GATM—chronic kidney failure	2.25e-05	0.000184	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	2.24e-05	0.000184	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LIPC—chronic kidney failure	2.24e-05	0.000184	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2C19—chronic kidney failure	2.24e-05	0.000184	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.21e-05	0.000182	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.21e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRKAG2—chronic kidney failure	2.21e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PRKD1—chronic kidney failure	2.21e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2B6—chronic kidney failure	2.21e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	2.17e-05	0.000177	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS1—chronic kidney failure	2.14e-05	0.000175	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KRAS—chronic kidney failure	2.14e-05	0.000175	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG1—chronic kidney failure	2.11e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SREBF2—chronic kidney failure	2.07e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SCARB1—chronic kidney failure	2.07e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIP5K1B—chronic kidney failure	2.06e-05	0.000169	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACAT1—chronic kidney failure	2.06e-05	0.000169	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTGS1—chronic kidney failure	2.05e-05	0.000168	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HBEGF—chronic kidney failure	2.04e-05	0.000167	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	2.02e-05	0.000166	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ARG2—chronic kidney failure	2.02e-05	0.000166	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.02e-05	0.000165	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SREBF1—chronic kidney failure	2.01e-05	0.000165	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	2.01e-05	0.000164	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCKR—chronic kidney failure	2e-05	0.000164	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCC3—chronic kidney failure	2e-05	0.000164	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LCAT—chronic kidney failure	1.98e-05	0.000162	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPIN1—chronic kidney failure	1.96e-05	0.00016	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMGCR—chronic kidney failure	1.96e-05	0.00016	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LRP2—chronic kidney failure	1.92e-05	0.000157	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2C18—chronic kidney failure	1.92e-05	0.000157	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—FASN—chronic kidney failure	1.91e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	1.91e-05	0.000157	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.83e-05	0.00015	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DDC—chronic kidney failure	1.82e-05	0.000149	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP3A4—chronic kidney failure	1.77e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRKD1—chronic kidney failure	1.77e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	1.77e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	1.77e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	1.75e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCA1—chronic kidney failure	1.74e-05	0.000143	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—chronic kidney failure	1.74e-05	0.000143	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.74e-05	0.000142	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.68e-05	0.000138	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SREBF2—chronic kidney failure	1.65e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—chronic kidney failure	1.63e-05	0.000134	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CPT1A—chronic kidney failure	1.63e-05	0.000134	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.63e-05	0.000133	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCC3—chronic kidney failure	1.6e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCKR—chronic kidney failure	1.6e-05	0.000131	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.59e-05	0.00013	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LIPC—chronic kidney failure	1.59e-05	0.00013	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2C19—chronic kidney failure	1.59e-05	0.00013	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPIN1—chronic kidney failure	1.56e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.56e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.54e-05	0.000126	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LRP2—chronic kidney failure	1.53e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	1.53e-05	0.000125	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.53e-05	0.000125	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—chronic kidney failure	1.5e-05	0.000123	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—chronic kidney failure	1.48e-05	0.000121	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—chronic kidney failure	1.47e-05	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SCARB1—chronic kidney failure	1.47e-05	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS1—chronic kidney failure	1.45e-05	0.000119	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—chronic kidney failure	1.44e-05	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SREBF1—chronic kidney failure	1.43e-05	0.000117	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DDC—chronic kidney failure	1.4e-05	0.000115	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMGCR—chronic kidney failure	1.39e-05	0.000114	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—chronic kidney failure	1.37e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.36e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.36e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.36e-05	0.000112	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.36e-05	0.000111	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FASN—chronic kidney failure	1.36e-05	0.000111	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A1—chronic kidney failure	1.32e-05	0.000108	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CPT1A—chronic kidney failure	1.3e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.28e-05	0.000105	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LIPC—chronic kidney failure	1.27e-05	0.000104	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	1.27e-05	0.000104	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.26e-05	0.000103	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.25e-05	0.000103	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.24e-05	0.000101	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.23e-05	0.000101	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.23e-05	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—chronic kidney failure	1.23e-05	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IRS1—chronic kidney failure	1.22e-05	0.0001	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARA—chronic kidney failure	1.21e-05	9.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.21e-05	9.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.18e-05	9.68e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.18e-05	9.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SCARB1—chronic kidney failure	1.17e-05	9.6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS1—chronic kidney failure	1.16e-05	9.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.14e-05	9.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SREBF1—chronic kidney failure	1.14e-05	9.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMGCR—chronic kidney failure	1.11e-05	9.07e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FASN—chronic kidney failure	1.08e-05	8.88e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—chronic kidney failure	1.07e-05	8.8e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—chronic kidney failure	1.05e-05	8.57e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—chronic kidney failure	1.03e-05	8.41e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1e-05	8.23e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	1e-05	8.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	9.98e-06	8.18e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCA1—chronic kidney failure	9.86e-06	8.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—chronic kidney failure	9.85e-06	8.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LIPC—chronic kidney failure	9.79e-06	8.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	9.79e-06	8.02e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—chronic kidney failure	9.7e-06	7.95e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A1—chronic kidney failure	9.36e-06	7.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SCARB1—chronic kidney failure	9.04e-06	7.41e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—chronic kidney failure	8.98e-06	7.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS1—chronic kidney failure	8.95e-06	7.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SREBF1—chronic kidney failure	8.78e-06	7.2e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—chronic kidney failure	8.73e-06	7.15e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—chronic kidney failure	8.59e-06	7.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARA—chronic kidney failure	8.56e-06	7.02e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMGCR—chronic kidney failure	8.54e-06	7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FASN—chronic kidney failure	8.36e-06	6.85e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—chronic kidney failure	8.35e-06	6.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—chronic kidney failure	8.12e-06	6.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—chronic kidney failure	7.74e-06	6.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCA1—chronic kidney failure	7.61e-06	6.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	7.48e-06	6.13e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—chronic kidney failure	6.98e-06	5.72e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—chronic kidney failure	6.97e-06	5.71e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARA—chronic kidney failure	6.84e-06	5.6e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—chronic kidney failure	6.78e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—chronic kidney failure	6.44e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—chronic kidney failure	6.37e-06	5.22e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KRAS—chronic kidney failure	6.28e-06	5.15e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—chronic kidney failure	6.27e-06	5.14e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—chronic kidney failure	6.09e-06	4.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—chronic kidney failure	5.97e-06	4.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	5.77e-06	4.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—chronic kidney failure	5.57e-06	4.57e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—chronic kidney failure	5.57e-06	4.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—chronic kidney failure	5.38e-06	4.41e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARA—chronic kidney failure	5.28e-06	4.32e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—chronic kidney failure	5.11e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—chronic kidney failure	5.08e-06	4.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—chronic kidney failure	4.86e-06	3.98e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—chronic kidney failure	4.45e-06	3.64e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—chronic kidney failure	4.3e-06	3.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—chronic kidney failure	3.92e-06	3.21e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—chronic kidney failure	3.75e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—chronic kidney failure	3.43e-06	2.81e-05	CbGpPWpGaD
